Assessment of d-dimer levels among breast carcinoma patients
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 7, Pages 9799-9802
AbstractBackground: To assess d-dimer levels among breast carcinoma patients
Materials & methods: A total of 100 breast carcinoma patients were enrolled. Complete demographic details of all the patients were obtained. Only those patients were included in which histopathologic confirmed diagnosis of breast carcinoma was present. A Performa was made and detailed clinical and medical history of all the patients was recorded. Blood samples were obtained from all the patients and serum D Dimer levels were evaluated using auto-analyser
Results: Mean D Dimer levels were found to be 2.74 μg/mL. Mean D-Dimer levels among patients with and without lymph node involvement was 2.981 μg/mL and 1.512 μg/mL respectively. Significant results were obtained while comparing the mean D-Dimer levels among patients with and without lymph node involvement.
Conclusion: D-Dimer levels are significant altered in breast cancer patients with lymph node involvement.
- Article View: 3
- PDF Download: 7